About Neuro-Pain Medical Center, Inc
Clinical Trials at Neuro-Pain Medical Center, Inc
During the past decade, Neuro-Pain Medical Center, Inc conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 7 clinical trials were completed, i.e. on
average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Neuro-Pain Medical Center, Inc" #1 sponsor was "Allergan" with 2 trials, followed by "Biogen" with 2 trials
sponsored, "Acorda Therapeutics" with 1 trials sponsored, "Bial - Portela C S.A." with 1 trials sponsored and "Eisai Inc."
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Neuro-Pain Medical Center, Inc"
#1 collaborator was "Sunovion" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Neuro-Pain Medical Center, Inc
According to Clinical.Site data, the most researched conditions in "Neuro-Pain Medical Center, Inc" are
"Alzheimer's Disease" (3 trials), "Migraine, With or Without Aura" (2 trials), "Back Pain Lower Back Chronic" (1 trials), "Drug Resistant Partial Onset Seizure" (1 trials) and "Epilepsy" (1 trials). Many other conditions were trialed in "Neuro-Pain Medical Center, Inc" in a lesser frequency.
Clinical Trials Intervention Types at Neuro-Pain Medical Center, Inc
Most popular intervention types in "Neuro-Pain Medical Center, Inc" are "Drug" (11 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "1200 mg QD Eslicarbazepine acetate" (1 trials), "800 mg QD Eslicarbazepine acetate" (1 trials), "Aducanumab" (1 trials) and "Atogepant" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Neuro-Pain Medical Center, Inc
The vast majority of trials in "Neuro-Pain Medical Center, Inc" are
11 trials for "All" genders.
Clinical Trials Status at Neuro-Pain Medical Center, Inc
Currently, there are NaN active trials in "Neuro-Pain Medical Center, Inc".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Neuro-Pain Medical Center, Inc,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Neuro-Pain Medical Center, Inc, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".